This website is intended for healthcare professionals in Canada. VNS Therapy™ for drug-resistant epilepsy is not available in all regions - please refer to your country-specific labeling.
Medical Education
Advance your knowledge, skills and expertise with continuous training and education programs.
Authors: Patrick Kwan, MD, BChir, FRACP, PhD; Jukka Peltola, MD PhD; Rainer Surges, MD, PhD; Stephen Karceski, MD; Robert Fisher, MD, PhD; John Stern, MD; Christianne Heck, MD, MMM, FAES
Drug-Resistant Epilepsy: Hot Topics in the Use of Neuromodulation
The goal of this activity is to improve clinicians’ understanding of drug-resistant epilepsy (DRE) and clinical trial findings regarding neuromodulation devices to help clinicians make evidence-based decisions about the use of neuromodulation devices in patients with DRE.
Upon completion of this activity, participants will have increased knowledge regarding:
- Consequences of drug-resistant epilepsy for patients
- Factors to consider when selecting an appropriate neuromodulation therapy for patients with drug-resistant epilepsy
- Long-term clinical data on the use of neuromodulation in patients with drug-resistant epilepsy
